5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow Shingles: new trials by email Literature Review of Shingles trials Research Report on Shingles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine JCXH-105, Active Control (Shingrix) - Herpes Zoster (HZ), Shingles | Phase 1 | Completed | Immorna Biotherapeutics, Inc. | 75 | 2023-05-26 | 2024-09-19 |
| Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers Z-1018, Shingrix - Shingles, Herpes Zoster | Phase 1 | Completed | Dynavax Technologies Corporation | 150 | 2022-01-10 | 2022-11-07 |
| Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds Zostavax, HZ/su vaccine, Placebo - Shingles, Herpes Zoster | Phase 1 | Completed | University of Colorado, Denver | 160 | 2014-05-01 | 2020-07-08 |
| Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents Varicella Zoster Virus Vaccine (Zostavax) - Immunosenescence, Shingles | Phase 1 | Completed | University of Colorado, Denver | 33 | 2010-11-01 | 2021-06-25 |
| Valacyclovir in Immunocompromised Children Valacyclovir - Shingles, Bone Marrow Transplantation | Phase 1 | Completed | Baylor College of Medicine | 37 | 1998-04-07 | 2020-03-04 |
Herpes Zoster (5) · Chickenpox (1) · Communicable Diseases (1) · Vaccine-Preventable Diseases (1)
DNA Virus Infections (5) · Herpesviridae Infections (5) · Infections (5) · Varicella Zoster Virus Infection (5) · Virus Diseases (5) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Herpes Zoster Vaccine (2) · Saline Solution (1) · Vaccines, Synthetic (1) · Valacyclovir (1)
University of Colorado, Denver (2) · Baylor College of Medicine (1) · Dynavax Technologies Corporation (1) · Immorna Biotherapeutics, Inc. (1)
United States (4) · Australia (1)
Adit A Ginde, MD, MPH (1) · Myron J Levin, M.D. (1) · Susan Blaney, MD (1)
PMID 30247596, PMID 34850039, PMID 37781954
K23AG040708 (1)